Abstract
The vast majority of peritoneal carcinomatosis occurs in the form of a secondary metastatic lesion. In Japan, the stomach is the most frequent origin of metastatic cancer in the abdominal cavity, while in Western countries the ovary is usually affected. The bile duct, large intestine, and breast are other primary sites. With cancerous invasion of the peritoneoserosal membrane, ascitic fluid frequently accumulates in the abdominal cavity and a terminal state can be thus identified.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dedrick RL, Myers CE, Bungay PM, DeVita VT Jr. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 1978;62:1–11.
Dedrick RL, Flessner MF, Collins JM, Schultz JS. Is the peritoneum a membrane? ASAIO J 1982;5:1–8.
Dedrick RL. Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 1985;12:1–6.
Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36–41.
Fujimoto S, Shretha MD, Kobayashi K, Koike S, Kokubun M, Kiuchi S, Takahashi M, Konno C, Okui K. Combined treatment with surgery and intraperitoneal hyperthermic perfusion (IPHP) for far-advanced gastrointestinal cancer with peritoneal seeding. Acta Med Austriaca 1989;16:76–80.
Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Takahashi M, Okui K. Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far-advanced or recurrent gastric cancer. Reg Cancer Treat 1989;2:198–202.
Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Takahashi M, Konno C, Ohta M, Kitsukawa Y, Mizutani M, Okui K. Clinical trials with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer 1989;64:154–160.
Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Ohta M, Takahashi M, Kitsukawa Y, Mizutani M, Chikenji T, Okui K. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1990;212:592–596.
Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Takahashi M, Okui K. Clinical outcome of combined therapy of intraoperative hyperthermochemotherapy and surgery for patients with peritoneal recurrence from gastric cancer. Reg Cancer Treat 1990;3:181–184.
Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mutou T, Ohkubo H. Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992;70:2754–2760.
Fujimoto S, Takahashi M, Kabayashi K, Kure M, Mutou T, Masaoka H, Ohkubo H. Relation between clinical and histologic outcome of intraperitoneal hyperthermic perfusion for patients with gastric cancer and peritoneal metastasis. Oncology 1993;50:338–343.
Fujimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, Sugiyama K, Hasagawa H, Katayama K, Miwa K, Miyazaki I. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65–71.
Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979;44:1476–1480.
Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232–237.
Sugarbaker PH, Landy D, Jaffe G, Pascal R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon and appendix. Cancer 1990;65:1495–1501.
Wangensteen OH, Lewis FJ, Tongen LA. The second-look in cancer surgery. Lancet 1951;71:303–307.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Fujimoto, S., Takahashi, M., Kobayashi, K., Kasanuki, J., Ohkubo, H. (1996). Heated intraperitoneal mitomycin C infusion treatment for patients with gastric cancer and peritoneal metastasis. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Drugs and Diseases. Cancer Treatment and Research, vol 81. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1245-1_20
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1245-1_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-3726-3
Online ISBN: 978-1-4613-1245-1
eBook Packages: Springer Book Archive